Assessment of malignant diseases post kidney transplantation at the University Hospital Leipzig

Assessment of malignant diseases post kidney transplantation at the University Hospital Leipzig - MAD-KIT / KTx-cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021669

Enrollment

250

Registered

2020-05-08

Start date

2020-01-31

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z94.0 C80

Interventions

Group 1: 1. Assessing incidence of malignant disease (incl. tumor entity) after renal transplantation. 2. Detecting single rare genetic factors predisposing for malignancy and genetic burden analysis

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Kidney transplantation

Exclusion criteria

Exclusion criteria: less than 18 years of age; hematopoietic stem cell transplantation

Design outcomes

Primary

Measure	Time frame
Statistical determination of prevalence including time point of onset (primary endpoint) of malignant disease after kidney transplantation (Ktx) at the University of Leipzig Medical Center in a retrospective analysis via electronic health records and updated information from clinical questionnaires.	—

Secondary

Measure	Time frame
Evaluation of a hereditary / genetic cause and susceptibility of malignant disease after renal transplantation via molecular genetic analysis.	—

Countries

Germany

Contacts

Public ContactJohannes Münch

Medizinische Klinik III, Fachabteilung Nephrologie

Johannes.muench@medizin.uni-leipzig.de0341 97 13350

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026